The impact of cost containment reforms to the Pharmaceutical Benefits Scheme (PBS) on prescribing volumes and expenditure in Australia: 1992-2011
| dc.contributor.author | Lee, Kah Seng | |
| dc.contributor.supervisor | Assoc. Prof. Rachael Moorin | |
| dc.contributor.supervisor | Dr Delia Hendrie | |
| dc.contributor.supervisor | Prof. Bruce Sunderland | |
| dc.date.accessioned | 2017-01-30T09:54:33Z | |
| dc.date.available | 2017-01-30T09:54:33Z | |
| dc.date.created | 2016-07-27T07:08:43Z | |
| dc.date.issued | 2014 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/836 | |
| dc.description.abstract |
Objectives: To investigate the impact of cost containment measures on PBS prescribing volumes and expenditure. Methods: Segmented linear regression models were used to analyse the time series data from Medicare Australia’s PBS Statistics. Seven measures and four new listing dates of statins were investigated. Results: Many of the cost containment measures were effective in containing costs. Conclusions: The safety net 20 days rule was estimated to be the most effective in reducing drugs utilisation and expenditure. | |
| dc.language | en | |
| dc.publisher | Curtin University | |
| dc.title | The impact of cost containment reforms to the Pharmaceutical Benefits Scheme (PBS) on prescribing volumes and expenditure in Australia: 1992-2011 | |
| dc.type | Thesis | |
| dcterms.educationLevel | MPhil | |
| curtin.department | School of Pharmacy | |
| curtin.accessStatus | Open access |